ARMISTICE CAPITAL, LLC

Position in SCLX — Scilex Holding Co

CIK 1601086 NEW YORK, NY

Position in SCLX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,982,698

-$3,832,714 QoQ

Shares Held

297,706

-37.5% QoQ

Ownership

3.51%

of shares outstanding

% of Portfolio

0.07%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

ARMISTICE CAPITAL, LLC holds $65,860,003 across 5 Drug Manufacturers - General names. SCLX ranks #5 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GRFS	Grifols SA	2,988,000	$23,963,760
2	SNY	Sanofi	300,000	$14,454,000
3	GSK	GSK plc	236,000	$13,024,840
4	BMY	Bristol Myers Squibb Co	205,024	$12,434,705
5	SCLX	Scilex Holding Co This page	297,706	$1,982,698

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,982,698	297,706	-37.5%	Shares	Sole	2026-05-15
2025-12-31	$5,815,412	476,674	+622.2%	Shares	Sole	2026-02-17
2025-09-30	$1,298,874	66,000	—	Shares	Sole	2025-11-17
No filing history on record for this holder in this stock.